ATK FOUNDATION
Registration# 1045524
Correspondent:
MR. RICHARD BERESFORD
MCDERMOTT WILL & EMERY
7 BISHOPSGATE
LONDON
EC2N 3AR
MR. RICHARD BERESFORD
MCDERMOTT WILL & EMERY
7 BISHOPSGATE
LONDON
EC2N 3AR
Telephone:020 7577 6905
Document:
MEMORANDUM AND ARTICLE OF ASSOCIATION INCORPORATED ON 9TH DECEMBER 1994, AS AMENDED BY SPECIAL RESOLUTION ON 13TH MARCH 1995.
MEMORANDUM AND ARTICLE OF ASSOCIATION INCORPORATED ON 9TH DECEMBER 1994, AS AMENDED BY SPECIAL RESOLUTION ON 13TH MARCH 1995.
Objects:
THE COMPANY'S OBJECTS ARE TO ATTACK AND DEFEAT THE DISEASE OF CANCER IN ALL ITS FORMS, TO INVESTIGATE ITS CAUSES, DISTRIBUTION, SYMPTOMS, PATHOLOGY AND TREATMENT AND TO PROMOTE ITS CURE AND IN PARTICULAR TO CONDUCT RESEARCH INTO AND TO COLLECT, CO-ORDINATE AND DISSEMINATE MEDICAL, SCIENTIFIC AND OTHER KNOWLEDGE, DATA, STATISTICS AND INFORMATION AS TO THE CAUSATION, OCCURRENCE, DISTRIBUTION, TREATMENT AND CURE OF OR OTHERWISE RELATING TO CANCER OR ANY OTHER RESEARCH, DATA, STATISTICS AND INFORMATION AS MAY SEEM EXPEDIENT AND TO ESTABLISH AND MAINTAIN RESEARCH INSTITUTES, LABORATORIES AND HOSPITALS ANYWHERE IN THE WORLD FOR THE CARRYING OUT OF SUCH RESEARCH, COLLECTION, CO-ORDINATION AND DISSEMINATION AS AFORESAID WITH PARTICULAR EMPHASIS ON BUT NOT CONFINED TO IMMUNOLOGICAL DISORDER AND THE PROCESS KNOWN AS AUTOLOGOUS TUMOR KILLING ACTIVITY.
THE COMPANY'S OBJECTS ARE TO ATTACK AND DEFEAT THE DISEASE OF CANCER IN ALL ITS FORMS, TO INVESTIGATE ITS CAUSES, DISTRIBUTION, SYMPTOMS, PATHOLOGY AND TREATMENT AND TO PROMOTE ITS CURE AND IN PARTICULAR TO CONDUCT RESEARCH INTO AND TO COLLECT, CO-ORDINATE AND DISSEMINATE MEDICAL, SCIENTIFIC AND OTHER KNOWLEDGE, DATA, STATISTICS AND INFORMATION AS TO THE CAUSATION, OCCURRENCE, DISTRIBUTION, TREATMENT AND CURE OF OR OTHERWISE RELATING TO CANCER OR ANY OTHER RESEARCH, DATA, STATISTICS AND INFORMATION AS MAY SEEM EXPEDIENT AND TO ESTABLISH AND MAINTAIN RESEARCH INSTITUTES, LABORATORIES AND HOSPITALS ANYWHERE IN THE WORLD FOR THE CARRYING OUT OF SUCH RESEARCH, COLLECTION, CO-ORDINATION AND DISSEMINATION AS AFORESAID WITH PARTICULAR EMPHASIS ON BUT NOT CONFINED TO IMMUNOLOGICAL DISORDER AND THE PROCESS KNOWN AS AUTOLOGOUS TUMOR KILLING ACTIVITY.
Benefit:
NOT DEFINED BUT IN PRACTICE TOKYO AND LONDON
NOT DEFINED BUT IN PRACTICE TOKYO AND LONDON
Operation:
Charity Operates inside and outside England and Wales
ASIA-JAPAN
EUROPE-UNITED KINGDOM
Charity Operates inside and outside England and Wales
ASIA-JAPAN
EUROPE-UNITED KINGDOM
History:
04 Apr 1995 Registered
12 Nov 2003 Removed(CEASED TO EXIST)
04 Apr 1995 Registered
12 Nov 2003 Removed(CEASED TO EXIST)
